FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043180 [Registered on: 13/06/2022] Trial Registered Prospectively
Last Modified On: 11/05/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   A study to verify the symptoms of Homoeopathic medicine Epigaea Repens in cases of urolithiasis 
Scientific Title of Study   An Interventional Study To Evaluate The Effectiveness Of Epigaea Repens In Cases Of Urolithiasis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Komal Yadav 
Designation  PG Student 
Affiliation  Dr MPK Homoeopathic Medical College Hospital and Research Centre 
Address  Department of Materia Medica Dr MPK Homoeopathic Medical College Hospital and Research Centre a constituent college of Homoeopathy University Saipura Sanganer Jaipur

Jaipur
RAJASTHAN
302029
India 
Phone  9929725886  
Fax    
Email  raokomal894@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jyoti Sharma 
Designation  Assistant Professor 
Affiliation  Dr MPK Homoeopathic Medical College Hospital and Research Centre 
Address  Department of Materia Medica Dr MPK Homoeopathic Medical College Hospital and Research Centre a constituent college of Homoeopathy University Saipura Sanganer Jaipur

Jaipur
RAJASTHAN
302029
India 
Phone  9785835468  
Fax    
Email  Jyotisharmasky11@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Komal Yadav 
Designation  PG Student 
Affiliation  Dr MPK Homoeopathic Medical College Hospital and Research Centre 
Address  Department of Materia Medica Dr MPK Homoeopathic Medical College Hospital and Research Centre a constituent college of Homoeopathy University Saipura Sanganer Jaipur

Jaipur
RAJASTHAN
302029
India 
Phone  9929725886  
Fax    
Email  raokomal894@gmail.com  
 
Source of Monetary or Material Support  
Dr Girendra Pal Homoeopathic Hospital and Research Centre 
 
Primary Sponsor  
Name  Dr MPK Homoeopathic Medical College Hospital and Research Center 
Address  Saipura Sanganer Jaipur pin code 302029 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Komal Yadav  Dr Girendra Pal Homoeopathic Hospital and Research Centre  Department of Materia Medica, Room No. 4, Unit 1 Dr. MPK Homoeopathic Medical College, Hospital and Research Centre, Homoeopathy University, 10, 11, 12, Hahnemann Marg, Diggi Malpura Road, Saipura Sanganer Jaipur Pin code 302029
Jaipur
RAJASTHAN 
9929725886

raokomal894@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Homoeopathy University Jaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N209||Urinary calculus, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Epigaea Repens  Oral administration of Epigaea Repens in either 30 or 200 potency in form of globules size 40. Dosage and Repeatition - bd or tds for seven days. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients giving consent for the study
2. Patients willing to have X-ray or USG (KUB) before and after treatment
3. Cases (symptomatic and asymptomatic) with radiological evidence (Ultrasound Whole Abdomen) of renal stone. No history of expulsion of calculi after the radiological investigations within one month period
4. Patients having any urinary symptoms due to renal stone
5. Only those cases will be selected which will be having symptom similarity with the medicine Epigaea Repens  
 
ExclusionCriteria 
Details  1. Females who want to conceive, are pregnant or lactating
2. Patients diagnosed with Chronic Kidney Disease, Nephrotic Syndrome
3. Cases of Hydronephrosis above grade II
4. Known cases of any other severe systemic disorders
5. Patient pursuing other treatment and are not willing to leave it
6. Gross developmental defects or structural abnormality of kidney 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
According to the scores obtained (pre and post treatment) from the Urolithiasis Symptom Scoring (USS) method  Pre scores will be taken at baseline of treatment and post scores will be assessed at the end of 12 weeks using
Urolithiasis Symptom Scoring (USS) method  
 
Secondary Outcome  
Outcome  TimePoints 
To verify the symptoms of Epigaea Repens in cases of Urolithiasis  12 months 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   15/06/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a non- randomized, open-label, single arm, uni-centre interventional study to evaluate the effectiveness of Epigaea Repens in cases of urolithiasis. The study will evaluate the extent of improvement in clinical symptoms due to renal calculi using Urolithiasis symptoms score (USS) as an assessment scale in cases of urolithiasis with Epigaea Repens  and will also ascertain the clinical proved symptoms of Epigaea Repens if any. The primary outcome measures will be according to the scores obtained (pre and post treatment) from the USS scoring method.  The secondary outcome measures  will be to verify the clinical symptoms of Epigaea Repens.

Null Hypothesis (H0) - Epigaea Repens is not effective in cases of urolithiasis.
Alternate Hypothesis (H1) - Epigaea Repens is effective in cases of urolithiasis. 
 
Close